Board Charter

01 Purpose & Scope

This Board Charter establishes the foundational governance framework for the Aevum Zenth Conglomerate ("the Company"). It delineates the authority, composition, duties, and operating procedures of the Board of Directors, ensuring alignment with fiduciary obligations, regulatory compliance, and long-term stakeholder value across all 400+ subsidiaries and operational divisions.

The Charter supersedes all prior internal governance directives and operates in conjunction with the Company's Bylaws, Code of Business Conduct, and applicable securities regulations in all jurisdictions of operation.

02 Composition & Structure

The Board of Directors shall consist of a minimum of nine (9) and a maximum of thirteen (13) members, as determined by the current Board resolution. The composition reflects diverse expertise across engineering, finance, law, technology, healthcare, and global operations.

All directors shall serve staggered three-year terms. Elections occur at the Annual General Meeting (AGM) via majority vote. Vacancies may be filled by majority vote of the remaining directors, subject to shareholder ratification at the next AGM.

03 Roles & Responsibilities

The Board exercises ultimate authority over corporate strategy, risk oversight, executive compensation, capital allocation, and governance compliance. Key responsibilities include:

• Strategic Direction: Approving long-term corporate strategy, M&A activity, and capital structure optimization across all divisions.
• Risk & Compliance: Overseeing enterprise risk management (ERM), regulatory adherence, cybersecurity posture, and environmental/sustainability compliance.
• Executive Oversight: Selecting, evaluating, and compensating the CEO; succession planning for senior leadership.
• Financial Stewardship: Reviewing audited financial statements, internal controls, dividend policy, and major capital expenditures exceeding $500M.
• Governance Integrity: Ensuring ethical conduct, whistleblower protection, and transparency in all corporate disclosures.

04 Board Committees

The Board delegates specialized oversight to standing committees, each governed by its own sub-charter. All committee members must be Independent Directors unless otherwise specified.

Committee chairs report findings directly to the full Board. The CEO may attend committee sessions at the invitation of the chair but holds no voting rights in committee deliberations.

05 Meeting Procedures

The Board shall convene no fewer than four (4) regular sessions annually, with additional special meetings called by the Chair, CEO, or any three (3) directors. Virtual attendance is permitted in compliance with applicable corporate law.

• Quorum: A majority of the total Board membership constitutes a quorum.
• Voting: Decisions require a majority vote of directors present. Ties result in referral to the next session or executive committee resolution.
• Executive Sessions: Independent directors shall meet without management presence at least twice annually to evaluate Board performance and CEO leadership.
• Materials: Comprehensive board packets must be distributed at least five (5) business days prior to meetings.

06 Independence & Conflict of Interest

Directors must adhere to strict independence standards aligned with major exchange listing requirements. Any material relationship with the Company, its subsidiaries, or related parties must be disclosed annually and reviewed by the Nominating & Governance Committee.

Conflicts of interest shall be managed through:

1. Mandatory written disclosure within 10 business days of identification
2. Recusal from voting and deliberation on related matters
3. Documentation in Board minutes and compliance registry
4. Annual certification of compliance with the Code of Business Conduct

07 Evaluation & Accountability

The Board shall conduct an annual evaluation encompassing three components:

• Self-Evaluation: Individual director assessment against skills, attendance, and contribution metrics.
• Board Effectiveness: Review of strategic oversight, committee performance, and governance alignment.
• Executive Assessment: CEO performance review tied to multi-year financial, operational, and ESG targets.

Evaluations are facilitated by an independent third-party governance consultant upon recommendation of the Chair. Results are confidential but inform succession planning, committee reassignments, and director nomination decisions.

08 Amendments & Governance Oversight

This Charter may be amended solely by a two-thirds (2/3) vote of the Board. Proposed amendments require 30-day notice to all directors and shareholder disclosure for material changes. The Company Secretary maintains the official registry of all governance documents.

The Charter shall be reviewed annually by the Nominating & Governance Committee to ensure alignment with evolving regulatory standards, industry best practices, and the Company's operational scale.

09 Governance Inquiries

All questions regarding Board governance, shareholder rights, or compliance disclosures should be directed to the Corporate Governance Office.